membre depuis:
Portefeuille démarré:
Dernière connexion:
10-10-17
12-10-17
17-05-24 16:09
Positions en cours
Date | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
27/11/20 | INNATE PHARMA | Achat | 300 E | 4.47 | 2.41 | -46.24% | -139 | 8 | |
18/11/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 7.88 | 7.41 | -6.16% | -18 | 9 | |
12/11/20 | INNATE PHARMA | Achat | 300 E | 3.82 | 2.41 | -37.07% | -111 | 7 | |
11/11/20 | INNATE PHARMA | Achat | 300 E | 3.85 | 2.41 | -37.57% | -113 | 4 | |
10/09/20 | INNATE PHARMA | Achat | 300 E | 3.39 | 2.41 | -29.08% | -87 | 7 | |
09/09/20 | INNATE PHARMA | Achat | 300 E | 3.68 | 2.41 | -34.68% | -104 | 5 | |
25/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.80 | 7.41 | 27.53% | 83 | 8 | |
13/05/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 6.60 | 7.41 | 12.06% | 36 | 6 | |
13/05/20 | ADVICENNE | Achat | 300 E | 7.72 | 2.12 | -72.67% | -218 | 4 | |
13/05/20 | ADVICENNE | Achat | 300 E | 7.72 | 2.12 | -72.67% | -218 | 4 | |
30/04/20 | ADVICENNE | Achat | 300 E | 8.82 | 2.12 | -76.09% | -228 | 6 | |
24/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 5.02 | 7.41 | 47.36% | 142 | 7 | |
23/04/20 | INNATE PHARMA | Achat | 300 E | 6.33 | 2.41 | -62.07% | -186 | 7 | |
21/04/20 | INNATE PHARMA | Achat | 300 E | 6.39 | 2.41 | -62.42% | -187 | 7 | |
20/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.38 | 7.41 | 68.91% | 207 | 6 | |
15/04/20 | ESKER | Achat | 300 E | 98.00 | 191.40 | 95.01% | 285 | 8 | |
08/04/20 | OSE IMMUNOTHERAPEUTICS | Achat | 300 E | 4.33 | 7.41 | 70.86% | 213 | 9 | |
01/04/20 | ESKER | Achat | 300 E | 89.50 | 191.40 | 113.54% | 341 | 22 | |
01/04/20 | ADVICENNE | Achat | 300 E | 7.30 | 2.12 | -71.09% | -213 | 22 | |
11/02/20 | INNATE PHARMA | Achat | 300 E | 6.95 | 2.41 | -65.46% | -196 | 21 | |
30/01/20 | ADVICENNE | Achat | 300 E | 10.00 | 2.12 | -78.92% | -237 | 22 | |
27/01/20 | ADVICENNE | Achat | 300 E | 9.60 | 2.12 | -78.04% | -234 | 23 | |
21/01/20 | YMAGIS | Achat | 300 E | 1.94 | 0.80 | -58.90% | -177 | 25 | |
Enregistrements 51 à 70 sur 70 |
Positions soldées
Date sortie | Valeur | Sens | Investi | Entrée | Dernier | Perf | Gain | Etat | Lu |
25/01/18 | ABIONYX PHARMA | Achat | 600 E | 2.34 | 2.62 | 11.75% | 71 | 7 | |
23/01/18 | GENOMIC VISION | Achat | 600 E | 3.46 | 3.19 | -8.00% | -48 | 7 | |
17/01/18 | RIBER | Achat | 600 E | 2.97 | 4.08 | 37.14% | 223 | 11 | |
04/01/18 | INNATE PHARMA | Achat | 1 000 E | 4.97 | 5.10 | 2.41% | 24 | 9 | |
08/12/17 | RIBER | Achat | 600 E | 3.52 | 3.59 | 1.79% | 11 | 6 | |
07/11/17 | ROCTOOL SA | Achat | 600 E | 6.91 | 8.92 | 28.86% | 173 | 6 | |
03/11/17 | RIBER | Achat | 600 E | 3.00 | 4.06 | 35.10% | 211 | 7 | |
30/10/17 | RIBER | Achat | 300 E | 3.19 | 3.68 | 15.15% | 45 | 11 | |
25/10/17 | RIBER | Achat | 300 E | 3.15 | 3.69 | 16.93% | 51 | 4 | |
25/10/17 | RIBER | Achat | 300 E | 3.06 | 3.55 | 15.80% | 47 | 4 | |
25/10/17 | RIBER | Achat | 300 E | 3.10 | 3.54 | 13.98% | 42 | 4 | |
23/10/17 | RIBER | Achat | 600 E | 2.95 | 3.20 | 8.27% | 50 | 6 | |
19/10/17 | RIBER | Achat | 600 E | 2.55 | 2.65 | 3.72% | 22 | 7 | |
16/10/17 | BASTIDE LE CONFORT | Achat | 2 000 E | 43.75 | 44.90 | 2.43% | 49 | 14 | |
Enregistrements 1001 à 1005 sur 1005 |